EFFECTS OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE ON THE PROLIFERATION OF HERPES-SIMPLEX VIRUS TYPE-1-TRANSFORMED AND THYMIDINE KINASE-DEFICIENT MOUSE CELLS

被引：12

作者：

BUBLEY, G

CRUMPACKER, C

DECLERCQ, E

SCHNIPPER, L

机构：

[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115

[2] CATHOLIC UNIV LEUVEN,REGA INST MED RES,B-3000 LOUVAIN,BELGIUM

[3] CHARLES A DANA RES INST,BOSTON,MA 02215

来源：

VIROLOGY | 1983年 / 129卷 / 02期

关键词：

D O I：

10.1016/0042-6822(83)90188-5

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：490 / 492

页数：3

共 50 条

[31] MURINE MAMMARY FM3A CARCINOMA-CELLS TRANSFORMED WITH THE HERPES-SIMPLEX VIRUS TYPE-1 THYMIDINE KINASE GENE ARE HIGHLY SENSITIVE TO THE GROWTH-INHIBITORY PROPERTIES OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE AND RELATED-COMPOUNDS
BALZARINI, J
DECLERCQ, E
AYUSAWA, D
SENO, T
FEBS LETTERS, 1985, 185 (01): : 95 - 100
[32] DIFFERENTIAL PHOSPHORYLATION OF (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE MONOPHOSPHATE BY THYMIDYLATE KINASES FROM HERPES-SIMPLEX VIRUSES TYPE-1 AND TYPE-2 AND VARICELLA ZOSTER VIRUS
FYFE, JA
MOLECULAR PHARMACOLOGY, 1982, 21 (02) : 432 - 437
[33] THE RELATIONSHIP BETWEEN INCORPORATION OF E-5-(2-BROMOVINYL)-2'-DEOXYURIDINE INTO HERPES-SIMPLEX VIRUS TYPE-1 DNA WITH VIRUS INFECTIVITY AND DNA INTEGRITY
MANCINI, WR
DECLERCQ, E
PRUSOFF, WH
JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (02) : 792 - 795
[34] Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase
Christine Grignet-Debrus
Vincent Cool
Nathalie Baudson
Bart Degrève
Jan Balzarini
Laurence De Leval
Serge Debrus
Thierry Velu
Claire-Michelle Calberg-Bacq
Cancer Gene Therapy, 2000, 7 : 215 - 223
[35] SELECTIVE-INHIBITION OF THE PROLIFERATION OF HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1)-TRANSFORMED MURINE MAMMARY FM3A CARCINOMA-CELLS BY (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE AND RELATED-COMPOUNDS
BALZARINI, J
DECLERCQ, E
AYUSAWA, D
SENO, T
ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1985, 93 (03): : B69 - B70
[36] TOPICAL TREATMENT OF CUTANEOUS HERPES-SIMPLEX VIRUS-INFECTION IN HAIRLESS MICE WITH (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE AND RELATED-COMPOUNDS
DECLERCQ, E
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) : 155 - 159
[37] Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-β-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase
Grignet-Debrus, C
Cool, V
Baudson, N
Degrève, B
Balzarini, J
De Leval, L
Debrus, S
Velu, T
Calberg-Bacq, CM
CANCER GENE THERAPY, 2000, 7 (02) : 215 - 223
[38] (E)-5-(2-bromovinyl)-2′-deosyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase-expressing cells
Hamel, W
Zirkel, D
Mehdorn, HM
Westphal, M
Israel, MA
CANCER GENE THERAPY, 2001, 8 (05) : 388 - 396
[39] ACTIVATION OF LATENT HERPES-SIMPLEX VIRUS TYPE-2 INFECTION INVITRO REQUIRES A (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE-SENSITIVE GENE-FUNCTION
SCHECK, AC
WIGDAHL, B
RAPP, F
INTERVIROLOGY, 1987, 27 (03) : 121 - 129
[40] ORAL (E)-5-(2-BROMOVINYL)-2'-DEOXYURIDINE IN SEVERE HERPES-ZOSTER
DECLERCO, E
DEGREEF, H
WILDIERS, J
DEJONGE, G
DROCHMANS, A
DESCAMPS, J
DESOMER, P
BRITISH MEDICAL JOURNAL, 1980, 281 (6249): : 1178 - 1178

← 1 2 3 4 5 →